We are live on ! Find out more
GAA

Green Alpha Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 118.1%
This Fund
S&P 500
This Quarter Est. Return
+3.05%
1 Year Est. Return
+118.1%
3 Year Est. Return
+267.27%
5 Year Est. Return
+298.06%
10 Year Est. Return
AUM
$102M
AUM Growth
-$7.59M
Cap. Flow
-$2.94M
Cap. Flow %
-2.89%
Top 10 Hldgs %
38.01%
Holding
116
New
1
Increased
15
Reduced
91
Closed
9

Top Sells

Rank Stock Value
1
AZTA icon
Azenta
AZTA
+$307K
2
EXAS
Exact Sciences
EXAS
+$293K
3
GTLB icon
GitLab
GTLB
+$279K
4
ISRG icon
Intuitive Surgical
ISRG
+$264K
5
YETI icon
Yeti Holdings
YETI
+$255K

Sector Composition

Rank Sector Weight
1 Technology 56.06%
2 Healthcare 13.52%
3 Industrials 9.56%
4 Utilities 6.59%
5 Consumer Discretionary 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRGV icon
76
Energy Vault
NRGV
$675M
$339K 0.33%
102,638
-2,861
-3% -$11.8K
JOBY icon
77
Joby Aviation
JOBY
$7.07B
$339K 0.33%
41,000
-942
-2% -$10.6K
PATH icon
78
UiPath
PATH
$9.55B
$317K 0.31%
28,577
-942
-3% -$12K
BETA
79
Beta Technologies Inc
BETA
$5.06B
$310K 0.31%
21,072
-301
-1% -$6.17K
RBRK icon
80
Rubrik
RBRK
$21.5B
$273K 0.27%
5,577
-243
-4% -$13.9K
GRAL
81
GRAIL Inc
GRAL
$3.56B
$268K 0.26%
5,192
-119
-2% -$9.22K
REGN icon
82
Regeneron Pharmaceuticals
REGN
$82.8B
$260K 0.26%
336
-45
-12% -$34.5K
TWST icon
83
Twist Bioscience
TWST
$9.47B
$252K 0.25%
+5,303
New +$238K
CSTL icon
84
Castle Biosciences
CSTL
$1.03B
$244K 0.24%
9,945
-291
-3% -$9.53K
VRTX icon
85
Vertex Pharmaceuticals
VRTX
$138B
$244K 0.24%
546
-79
-13% -$36.8K
DUOL icon
86
Duolingo
DUOL
$6.81B
$242K 0.24%
2,454
-61
-2% -$7.52K
PACB icon
87
Pacific Biosciences
PACB
$469M
$241K 0.24%
182,618
-848
-0.5% -$1.52K
GH icon
88
Guardant Health
GH
$22.2B
$237K 0.23%
2,570
-290
-10% -$29.1K
AWK icon
89
American Water Works
AWK
$27.2B
$230K 0.23%
1,691
-178
-10% -$23.5K
PD icon
90
PagerDuty
PD
$1.05B
$223K 0.22%
35,880
-792
-2% -$6.85K
PRMB
91
Primo Brands
PRMB
$8.25B
$218K 0.21%
11,565
-2,022
-15% -$39.1K
ARCT icon
92
Arcturus Therapeutics
ARCT
$426M
$217K 0.21%
28,138
-144
-0.5% -$1.05K
SOPH icon
93
SOPHiA GENETICS
SOPH
$751M
$213K 0.21%
42,952
-2,708
-6% -$13.2K
SNPS icon
94
Synopsys
SNPS
$87B
$204K 0.2%
514
-69
-12% -$31.2K
TEAM icon
95
Atlassian
TEAM
$48.2B
$201K 0.2%
2,950
-69
-2% -$6.8K
NTLA icon
96
Intellia Therapeutics
NTLA
$1.86B
$182K 0.18%
14,167
-2,526
-15% -$32.2K
SLP icon
97
Simulations Plus
SLP
$372M
$162K 0.16%
13,706
-419
-3% -$6.18K
RELY icon
98
Remitly
RELY
$5.48B
$159K 0.16%
10,137
-1,661
-14% -$24.6K
GWH icon
99
ESS Tech
GWH
$13.9M
$134K 0.13%
114,580
-4,103
-3% -$6.32K
INO icon
100
Inovio Pharmaceuticals
INO
$131M
$114K 0.11%
65,580
-6,515
-9% -$10.7K

Similar funds

Green Alpha Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Green Alpha Advisors held 116 positions worth $102M, down 7% from $109M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Green Alpha Advisors's Q1 2026 filing shows 1 new, 15 increased, 91 reduced and 9 closed positions. Its largest new stake was Twist Bioscience: 5,303 shares worth $252K. The largest sale was Azenta, an estimated $307K.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 53% a quarter earlier, followed by Healthcare and Industrials.

  • Green Alpha Advisors's largest Q1 2026 buy was Twist Bioscience: 5,303 shares worth $252K.
  • Green Alpha Advisors added most to Horizon Technology Finance in Q1 2026, an estimated $181K increase.
  • Green Alpha Advisors's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $79.5K.
  • Green Alpha Advisors fully exited Azenta in Q1 2026, selling an estimated $307K.
  • Green Alpha Advisors's ten largest holdings make up 38% of its $102M portfolio in Q1 2026.
  • Green Alpha Advisors opened 1 new position and closed 9 in Q1 2026.
  • Green Alpha Advisors's portfolio value fell 7% quarter-over-quarter to $102M.

Based on Green Alpha Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.